Specialized NGS panel for lung cancer genomics and clinical diagnostics. Delivers targeted genetic profiling for oncology applications in pulmonary disease.
Manufactured by
Genes 2Me Private Ltd
Gurugram, Haryana, India
Manufactures molecular diagnostic solutions including next-generation sequencing panels for oncology and clinical genomics, real-time PCR testing kits, and point-of-care molecular diagnostic systems. Specializes in precision NGS panels, validated RT-PCR assays for disease detection including cancer biomarkers and infectious diseases, and nucleic acid extraction kits. Products serve applications in oncology, maternal and child care, infectious disease testing, and personalized medicine diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 4 relevant products
TRUPCR Europe Ltd
United Kingdom · 3 relevant products
PlexBio Co., Ltd.
Taiwan · 5 relevant products
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 98 closest product alternatives
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Comprehensive genetic screening kit for lung cancer biomarkers and mutations. Enables early detection and treatment planning for pulmonary malignancies.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for detecting mutations associated with lung cancer. This panel identifies genetic alterations relevant to lung cancer diagnosis and treatment planning.
PlexBio Co., Ltd. · Taiwan
A qualitative diagnostic test for the detection of targeted 74 DNA mutation hotspots in non-small cell lung cancer (NSCLC) using circulating cell-free DNA (cfDNA). This assay enables advanced molecular testing for oncology applications.
95 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products